[{"address1": "7 Times Square", "address2": "Suite 2503", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 505158, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.34, "open": 1.36, "dayLow": 1.36, "dayHigh": 1.47, "regularMarketPreviousClose": 1.34, "regularMarketOpen": 1.36, "regularMarketDayLow": 1.36, "regularMarketDayHigh": 1.47, "payoutRatio": 0.0, "beta": 2.54, "forwardPE": -3.2558138, "volume": 2417456, "regularMarketVolume": 2417456, "averageVolume": 1971920, "averageVolume10days": 1403720, "averageDailyVolume10Day": 1403720, "bid": 1.36, "ask": 1.41, "bidSize": 3, "askSize": 3, "marketCap": 132367760, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 1.84, "fiftyDayAverage": 1.1892, "twoHundredDayAverage": 1.1845, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 114300368, "profitMargins": 0.0, "floatShares": 90562342, "sharesOutstanding": 94548400, "sharesShort": 7774815, "sharesShortPriorMonth": 7845644, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0856, "heldPercentInsiders": 0.003, "heldPercentInstitutions": 0.06553, "shortRatio": 7.59, "shortPercentOfFloat": 0.0857, "impliedSharesOutstanding": 94548400, "bookValue": 0.128, "priceToBook": 10.937499, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -30881000, "trailingEps": -0.5, "forwardEps": -0.43, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": 0.15702474, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 1.4, "targetHighPrice": 7.5, "targetLowPrice": 4.0, "targetMeanPrice": 5.83333, "targetMedianPrice": 6.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 13886000, "totalCashPerShare": 0.153, "totalDebt": 1001000, "quickRatio": 1.46, "currentRatio": 1.717, "debtToEquity": 10.576, "returnOnAssets": -1.5356599, "returnOnEquity": -41.478836, "freeCashflow": -24253624, "operatingCashflow": -35402000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "cryptoTradeable": false, "fiftyTwoWeekLowChangePercent": 0.8181818, "fiftyTwoWeekRange": "0.77 - 1.84", "fiftyTwoWeekHighChange": -0.44000006, "fiftyTwoWeekHighChangePercent": -0.23913047, "fiftyTwoWeekChangePercent": 15.702475, "dividendDate": 1573171200, "earningsTimestamp": 1742501101, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.5, "epsForward": -0.43, "epsCurrentYear": -0.42333, "priceEpsCurrentYear": -3.3071125, "fiftyDayAverageChange": 0.21079993, "fiftyDayAverageChangePercent": 0.17726196, "twoHundredDayAverageChange": 0.2155, "twoHundredDayAverageChangePercent": 0.1819333, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "postMarketTime": 1745625592, "regularMarketTime": 1745611201, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 4.4776073, "regularMarketPrice": 1.4, "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "postMarketChangePercent": 1.42143, "postMarketPrice": 1.4199, "postMarketChange": 0.0199, "regularMarketChange": 0.059999943, "regularMarketDayRange": "1.36 - 1.47", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1971920, "fiftyTwoWeekLowChange": 0.63, "displayName": "SELLAS Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]